We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BeyondSpring’s Plinabulin Improved Survival in 2nd and 3rd Line Lung Cancer Patients
BeyondSpring’s Plinabulin Improved Survival in 2nd and 3rd Line Lung Cancer Patients
BeyondSpring Pharmaceuticals’ lung cancer drug plinabulin showed statistically significant improvement in overall survival in its phase 3 trial conducted in China.
